Science & Technology
Antibody-based prertargeted alpha particle therapy for ovarian cancer
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R42CA287696-01
Award Ceiling
$392K
Award Floor
$392K
Close Date
May 31, 2025
Total Funding
$392K
Expected Awards
1
Posted Date
Jun 5, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R42CA287696-01
Description
STTR Phase Phase I award: "Antibody-based prertargeted alpha particle therapy for ovarian cancer" awarded to VIEWPOINT MOLECULAR TARGETING, INC. in CORALVILLE, Iowa. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $391,553. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.